NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Evaluation of Depression Symptoms and Brain Activity Associated With Response to Treatment of Depression

NCT00200902

CompletedPhase 4

Sponsor: University of California, Los Angeles

Conditions: Depression

Interventions: Venlafaxine (Effexor), Duloxetine (Cymbalta), Escitalopram (Lexapro), Placebo, Interpersonal Clinical Interaction (ICI)

Countries: United States

This study will use measurements of depression symptoms and brain activity to determine what factors may influence an individual's response to treatment for depression.

Eligibility overview

Sex: ALL

Age: 18 Years to 65 Years

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* Clinical diagnosis of unipolar major depression

Exclusion Criteria:

* Substance abuse
* Psychotic disorder
* History of severe head trauma

Locations (1)

Los Angeles, California, United States